Aigen Investment Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-4,515
| Closed | -$371K | – | 774 |
|
|
2022
Q1 | $371K | Buy |
4,515
+1,076
| +31% | +$88.4K | 0.06% | 328 |
|
|
2021
Q4 | $483K | Buy |
+3,439
| New | +$483K | 0.03% | 640 |
|
|
2021
Q3 | – | Sell |
-4,105
| Closed | -$663K | – | 697 |
|
|
2021
Q2 | $663K | Sell |
4,105
-2,248
| -35% | -$363K | 0.12% | 193 |
|
|
2021
Q1 | $1.09M | Buy |
6,353
+1,862
| +41% | +$319K | 0.14% | 162 |
|
|
2020
Q4 | $986K | Sell |
4,491
-1,738
| -28% | -$382K | 0.13% | 206 |
|
|
2020
Q3 | $1.03M | Buy |
+6,229
| New | +$1.03M | 0.13% | 244 |
|
|
2020
Q1 | – | Sell |
-1,845
| Closed | -$238K | – | 1646 |
|
|
2019
Q4 | $238K | Buy |
+1,845
| New | +$238K | 0.04% | 505 |
|